The DOI matches its Crossref record.
Transfer of Autoimmune Diabetes Mellitus with Splenocytes from Nonobese Diabetic (NOD) Mice
Abstract
The nonobese diabetic (NOD) mouse, a model of human type I diabetes, develops insulitis beginning at 4–6 wk of age. By 30 wk of age, 72% of females and 39% of males develop spontaneous diabetes, apparently because of an overwhelming autoimmune response to the insulin-producing β-cells within the islets. To identify the immune mechanism responsible for destruction of β-cells in the NOD mouse, we developed an adoptive transfer protocol that induces diabetes in NOD mice at an age when spontaneous diabetes is rarely observed. Splenocytes from overtly diabetic NOD mice were unable to transfer diabetes to very young (≤6 wk) irradiated NOD mice but effectively transferred diabetes to irradiated NOD mice 6 wk of age. In such transfers, overt diabetes was induced within 12–22 days in >95% (79/82) of the recipients. Thus, transfer of splenocytes to young mice induces them to become diabetic at a higher frequency and at a younger age than their untreated littermates. Equally successful transfers with as few as 5 × 106 spleen cells have been performed in male and female NOD mice, even though males display a lower spontaneous incidence of diabetes than females. Splenocytes obtained from diabetic mice maintained on insulin for up to 2 mo also transferred diabetes. Because NOD mice display increasing levels of insulitis with age, spleen cells obtained from nondiabetic NOD mice of different ages were tested for their ability to transfer diabetes. Spleen cells obtained from 7-wk-old nondiabetic donors were unable to transfer disease, suggesting that high numbers of effector cells are not yet present in the spleens of young NOD mice. In contrast, spleen cells obtained from most nondiabetic NOD mice >15 wk of age were able to transfer diabetes, indicating that the donor need not be overtly diabetic at the time of transfer. Our study provides direct demonstration of the immunological nature of the diabetic disease process in the NOD mouse and provides a method to determine which cells are the effectors of β-cell destruction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
THE NOD MOUSE: A Model of Immune Dysregulation
Anderson, M. S., & Bluestone, J. A. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115643 · Cited by 1,113
The Nonobese Diabetic Mouse as a Model of Autoimmune Diabetes: Immune Dysregulation Gets the NOD
Delovitch, T. L., & Singh, B. (1997) · Immunity · doi:10.1016/s1074-7613(00)80392-1 · Cited by 676
Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat
Castano, L., & Eisenbarth, G. S. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.003243 · Cited by 644
Genetic Control of Autoimmune Diabetes in the NOD Mouse
Wicker, L. S. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.179 · Cited by 589
Self-citationBendelac, A., Carnaud, C., Boitard, C., & Bach, J. F. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.4.823 · Cited by 569
Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin.
Zhang, Z. J., Davidson, L., Eisenbarth, G., & Weiner, H. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10252 · Cited by 563
The Murine Autoimmune Diabetes Model: NOD and Related Strains
Kikutani, H., & Makino, S. (1992) · Advances in Immunology · doi:10.1016/s0065-2776(08)60490-3 · Cited by 496
Autoimmune Diseases: The Failure of Self Tolerance
Sinha, A. A., Lopez, M. T., & McDevitt, H. O. (1990) · Science · doi:10.1126/science.1972595 · Cited by 493
Hammond, K. J. L., Poulton, L. D., Palmisano, L. J., Silveira, P. A., Godfrey, D. I., & Baxter, A. G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.7.1047 · Cited by 474
Tian, J., Atkinson, M. A., Clare-Salzler, M., Herschenfeld, A., Forsthuber, T., Lehmann, P. V., & Kaufman, D. L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1561 · Cited by 426
Corbett, J. A., Sweetland, M. A., Wang, J. L., Lancaster, J. R., & McDaniel, M. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1731 · Cited by 411
Acceleration of Diabetes in Young Nod Mice with a CD4 + Islet-specific T Cell Clone
Haskins, K., & McDuffie, M. (1990) · Science · doi:10.1126/science.2205920 · Cited by 382
Elias, D., Reshef, T., Birk, O. S., van der Zee, R., Walker, M. D., & Cohen, I. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3088 · Cited by 371
Daniel, D., Gill, R. G., Schloot, N., & Wegmann, D. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250430 · Cited by 358
Jacob, C. O., Aiso, S., Michie, S. A., McDevitt, H. O., & Acha-Orbea, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.3.968 · Cited by 349
Lund, T., O'Reilly, L., Hutchings, P., Kanagawa, O., Simpson, E., Gravely, R., Chandler, P., Dyson, J., Picard, J. K., Edwards, A., et al. (1990) · Nature · doi:10.1038/345727a0 · Cited by 331
Aerosol Insulin Induces Regulatory CD8 γδ T Cells That Prevent Murine Insulin-dependent Diabetes
Harrison, L. C., Dempsey-Collier, M., Kramer, D. R., & Takahashi, K. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2167 · Cited by 310
Mueller, R., Krahl, T., & Sarvetnick, N. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.1093 · Cited by 306
Yang, X. D., Tisch, R., Singer, S. M., Cao, Z. A., Liblau, R. S., Schreiber, R. D., & McDevitt, H. O. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.995 · Cited by 303
Wogensen, L., Lee, M. S., & Sarvetnick, N. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1379 · Cited by 294
Insulin‐specific T cells are a predominant component of islet infiltrates in pre‐diabetic NOD mice
Wegmann, D. R., Norbury‐Glaseru, M., & Danielf, D. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240820 · Cited by 279
Prevention of Type I Diabetes in NOD Mice by Adjuvant Immunotherapy
Sadelain, M. W. J., Qin, H.-Y., Lauzon, J., & Singh, B. (1990) · Diabetes · doi:10.2337/diab.39.5.583 · Cited by 275
Tian, J., Clere-Salzler, M., Herschenfeld, A., Middleton, B., Newman, D., Mueller, R., Arita, S., Evans, C., Atkinson, M. A., Mullen, Y., et al. (1996) · Nature Medicine · doi:10.1038/nm1296-1348 · Cited by 259
Self-citationKolb, H. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030308 · Cited by 259
Prevention of diabetes in NOD mice treated with antibody to murine IFNγ
Debray-Sachs, M., Carnaud, C., Boitard, C., Cohen, H., Gresser, I., Bedossa, P., & Bach, J.-F. (1991) · Journal of Autoimmunity · doi:10.1016/0896-8411(91)90021-4 · Cited by 258
T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice.
Boitard, C., Yasunami, R., Dardenne, M., & Bach, J. F. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.5.1669 · Cited by 256
Ferris, S. T., Carrero, J. A., Mohan, J. F., Calderon, B., Murphy, K. M., & Unanue, E. R. (2014) · Immunity · doi:10.1016/j.immuni.2014.09.012 · Cited by 164
Androgen treatment prevents diabetes in nonobese diabetic mice
Fox, H. S. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.175.5.1409 · Cited by 158
Metadata
- Authors
- Wicker, L. S., Miller, B. J., & Mullen, Y.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1986-08-01
- Volume
- 35
- Issue
- 8
- Pages
- 855-860
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2126323534
- Cited by
- 381
- References
- 0
- FWCI
- 7.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.